Supreme Appoints John Fowler President & Director

DECEMBER 19, 2014   Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. Friday December 19th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWF – OTC) (“SL” – CSE) is pleased to report that at its annual meeting today […]

Supreme Completes Pre-License Upgrades at Kincardine Greenhouse

DECEMBER 12, 2014   Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. December 12, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWF – OTC) (“SL” – CSE) is pleased to report that the Company has completed the security and infrastructure […]

Supreme Completes Private Placement for Aggregate Total of $1.78M

NOVEMBER 17, 2014 Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. November 17, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (SL:CSE) is pleased to announce that it has closed the final tranche of its previously announced unit financing […]

Supreme Pharmaceuticals Provides Update on Funding Kincardine Facility and Leadership Ahead of Investor Meeting

NOVEMBER 06, 2014 Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. November 6, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the“Company”) (SPRWF – OTC) (“SL” – CSE)in conjunction with an “Investor Meet and Greet” to be held today at the Fairmont Pacific […]

Supreme Completes First Tranche of Previously Announced Private Placement

NOVEMBER 05, 2014   Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. November 5, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“)(SL:CSE) is pleased to announce that it has closed the first tranche of its previously announced unit financing […]

Supreme Announces Private Placement Financing to Increase

OCTOBER 30, 2014   Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. October 30, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (“SL” – CSE) is pleased to announce that is has increased the maximum size of its previously […]

Supreme Provides Update on Okanagan Facility

OCTOBER 29, 2014 Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. October 29, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (“SL” – CSE) today announced that it has been advised by one of its partners, the operator of […]

Supreme Announces Financing

OCTOBER 22, 2014 Not For Dissemination In The United States. Failure To Comply With This Restriction May Constitute A Violation Of United States Securities Law. October 22, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (“SL” – CSE) is pleased to announce that it is undertaking a non-brokered private placement of up to […]

Supreme Resources LTD Announces New Officers and Directors

OCTOBER 10, 2014 SUPREME RESOURCES LTD. (“Supreme” or the “Corporation”) (TSX-V:SPR) announces that David Stadnyk and Tatiana Kovaleva, both of Vancouver, BC, have been appointed as the CEO and CFO respectively. Stephen Kenwood and James T. Rabbitt have resigned from the board and been replaced by David Stadnyk and George Tsafalas, also from Vancouver. Allan Levien, former CEO, […]

Supreme Completes Final Closing of the Previously Announced Private Placement

OCTOBER 06, 2014   NOT FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. SUPREME COMPLETES FINAL CLOSING OF THE PREVIOUSLYANNOUNCED PRIVATE PLACEMENT October 6, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (SL:CSE) is pleased to announce that it has […]

Supreme Resources LTD Announces Closing of Financing

SEPTEMBER 30, 2014 SUPREME RESOURCES LTD. (“Supreme” or the “Corporation”) (TSX-V: “SPR”) announces that the Company has closed its previously announced non-brokered private placement. 79,900,000 Common Share Units at $0.005 per unit were issued for total gross proceeds of $399,500. Each Unit consists of one common share and one common share purchase warrant. Each warrant is exercisable for […]

Supreme Appoints Chris Bechtel to Advisory Board

SEPTEMBER 23, 2014 September 23rd, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWF – OTC) (“SL” – CSE)is pleased to announce the appointment of Chris Bechtel to its advisory board. Mr. Bechtel brings a wealth of experience in capital markets, start-ups, and medicinal marijuana to the Company. Mr. Bechtel launched a small business […]

Supreme Completes First Tranche of Previously Announced Private Placement

SEPTEMBER 22, 2014 September 22, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (SL:CSE) is pleased to announce that it has closed the first tranche of its previously announced unit financing (see news releases dated August 15th and September 4, 2014) for total gross proceeds of $2,239,232.50 (the “Financing“). At closing, Supreme issued […]

Supreme Retains Capital Markets Advisor

SEPTEMBER 18, 2014 September 18th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (“SL” – CSE) is pleased to announce that it has engaged Merriman Capital, Inc. (“Merriman”), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX:MERR) as its Capital Markets Advisor. As part of the engagement, Merriman will act as Principal American Liaison (PAL) […]

Supreme Provides Construction Update

SEPTEMBER 16, 2014   September 16th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWF – OTC) (“SL” – CSE) is pleased to report that it has made significant progress regarding the construction and required security implementation at its 342,000 square foot greenhouse facility located in Kincardine, Ontario (the “Greenhouse”). Backed by strong support from […]

Supreme Updates Financing and Announces Launch of New Website

SEPTEMBER 03, 2014   September 3rd, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (“SL” – CSE) wishes to announce its intention to offer securities under the previously announcednon-brokered private placement (see news release dated August 15th, 2014) of up to 20 million units in the capital of the corporation (“Units”) at a price of $0.25 […]

Supreme Pharmaceuticals Inc. Announces Financing

AUGUST 15, 2014   August 15, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC)  (“SL” – CSE)is pleased to announce that it is undertaking a non-brokered private placement of up to 20 million units in the capital of the Corporation ( “Units”) at a price of $0.25 per Unit for aggregate gross proceeds […]

Share to Trade on a Consolidated Basis on July 31 2014

JULY 28, 2014   July 28, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE) is pleased to report that in respect to its previously announced intention to consolidate its issued and outstanding share capital on the basis of five (5) current shares for one (1) new share, its shares […]

Supreme to Evaluate US Opportunities and Provides Update

JULY 22, 2014   July 22nd, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD– OTC) (“SL” – CSE) is pleased to report that through the company’s newly formed subsidiary, Supreme Pharmaceuticals USA Inc., it is in the preliminary stages of evaluating medical cannabis investment opportunities within the State of Arizona, in the US. These […]

Supreme Pharmaceuticals Inc. Completes Shares for Debt Transaction

JULY 22, 2014 July 22, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE) announced that it has entered into Settlement Agreements with two creditors to settle debts owing to them by the issuance of a total of 652,500 common shares at a deemed issue price of $0.07 […]

Supreme Pharmaceuticals Inc. Announces Share Consolidation

JULY 18, 2014   July 18, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)announces that it will be proceeding with a 5 to 1 share consolidation such that a holder of 5 currently issued and outstanding shares will receive 1 new share. Fractional shares will be […]

Supreme to Attend Green Rush Financial Conference June 26 2014

JUNE 26, 2014 June 25, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to announce that the Company will be attending the second Green Rush Financial Conference of 2014 in Toronto, Ontario, on Thursday June 26, 2014. The Company will be exhibiting at booth #311from the hours […]

South Okanagan MMPR Application Update

JUNE 18, 2014   June 18th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to report that the target company (or the “Vendor”) at Facility 1 has received and replied to the Department of Health Canada on its Marihuana for Medical Purposes Regulations Licence (MMPR) […]

Supreme Pharmaceuticals Inc. Commences Construction of Required Security Measures

JUNE 06, 2014 June 6, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to report that the Company has commenced the construction of the required security upgrades on its recently acquired greenhouse. The Company is working with mechanical engineers, security consultants, architects, fire and rescue […]

Supreme Pharmaceuticals Inc. Closes Corporate Acquisition

JUNE 03, 2014 June 3, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to report that the Company has closed the previously announced arms-length acquisition of a Southern Ontario based company (the “Target Company”) that holds a pre-build Marijuana for Medical Purposes Regulations licence (“MMPR […]

Supreme Pharmaceuticals Acquires Ontario Greenhouse Complex for Future Medical Marijuana Production

MAY 23, 2014 May 23, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to announce that subsequent to its visit to the 342,000 square foot green house facility in Southern Ontario, Supreme has closed its purchase. The facility is located approximately 100 miles outside of […]

Supreme Pharmaceuticals Senior Management to Visit Southern Ontario Facility

MAY 16, 2014 May 16, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to announce that senior management of the target company and of Supreme will visit the 342,000 square foot facility in Southern Ontario early next week, of which Supreme currently has the option […]

Supreme Pharmaceuticals Inc. Announces Second Acquisition target

MAY 13, 2014 May 13th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to report that the Company has signed a letter of intent (“LOI”) to acquire a green house facility and 100% of a Southern Ontario based company (the “Target Company”) that has been […]

Supreme Grants Incentive Options

MAY 05, 2014 May 5th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE) has granted 12,000,000 incentive stock options to directors, officers and consultants at an exercise price of $0.05 for a term of five years from this day May 5th, 2014. Contact Information Investor Relations 430 – 580 […]

Supreme Reports MMPR Application Submittal

APRIL 28, 2014 April 28th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE) is pleased to report that the South Okanagan producing facility, which will from hereon in be referred to as “Facility 1”, has now formally submitted an MMPR application to Department of Health Canada. As part of […]

Supreme Completes Payment for Option to Purchase Producing Medical Marijuana Facility

APRIL 25, 2014 April 25, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE) announces that it has paid the option price by way of $150,000 in cash and issued 2,000,000 common shares for the previously announced option with respect to the producing medical marijuana facility in the South Okanagan. […]

Supreme Secures Option to Purchase Producing Medical Marijuana Facility

APRIL 22, 2014 April 22nd, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE)is pleased to announce that after completion of its due diligence and the completion of other conditions, it has acquired the previously announced option with respect to the producing medical marijuana facility in the South Okanagan […]

Supreme to Trade on the Canadian Securities Exchange

APRIL 21, 2014 April 21st, 2014, Calgary, AB – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE) announces that the Company is moving its listing from the TSX Venture Exchange to the Canadian Securities Exchange (CSE, formerly the CNSX) today under the symbol SL. This move will allow the efficient and seamless transition […]

Supreme Extends Due Diligence and Cancels Private Placement

APRIL 15, 2014 CALGARY, ALBERTA–(Marketwired – April 15, 2014) – Supreme Pharmaceuticals Inc. (the “Company”) (OTCBB:SPRWD)(TSX VENTURE:SL) reports that the parties to the agreement to acquire the South Okanagan producing medical marijuana facility, have mutually agreed upon an extension of the due diligence period to April 29th, 2014. In addition, the Company has cancelled its plans […]

Supreme Enters into Negotiations for an Additional Medical Marijuana Producing Facility

APRIL 14, 2014 April 14th, 2014, Calgary, AB – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – TSX.V) reports that the Company has entered into negotiations with a producing medical marijuana facility to acquire that business. This is in addition to the South Okanagan producing facility currently under evaluation. The parties have agreed to […]

Supreme Extends Due Diligence Period

APRIL 04, 2014 April 4th, 2014, Calgary, AB – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – TSX.V) reports that the parties have extended the due diligence period in respect to the Company’s peviously announced option agreement for an additional 7 business days until April 10, 2014. While due diligence results have been positive […]

Executive Management Visits Producing Facility as Part of Due Diligence

APRIL 01, 2014 April 1st, 2014, Calgary, AB – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – TSX.V) advises that management is currently visiting the producing medical marijuana facility on which the Company may acquire an option to purchase, as part of its due diligence. The facility is located in the south Okanagan and […]

Supreme Announces Proposed Name Change and Additional Line of Business

JANUARY 29, 2014   SUPREME RESOURCES LTD.(“Supreme” or the “Corporation”)(TSX-V: “SPR”) announces that it will, subject to regulatory approval, change its name to Supreme Pharmaceuticals Inc. in conjunction with its recent decision to pursue interests in pharmaceuticals or biomedical devices. David Stadnyk, President, stated “The current management team of the Corporation has had highly successful experiences with finding […]